ScreenerHero

INCR InterCure Ltd.

NAS · US · Healthcare · Drug Manufacturers - Specialty & Generic · intercure.co
5.130USD-3.57%Mkt Cap: 76.97M $P/E: —

InterCure Ltd., together with its subsidiaries, engages in the production, manufacturing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The c…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$66.23BUSDP/E 25.7
TAK
Takeda Pharmaceutical Company Limited
$58.68BUSD
TEVA
Teva Pharmaceutical Industries Limited
$45.70BUSDP/E 65.3
GALD
Galderma Group AG
$43.27BUSDP/E 56.1
HLN
Haleon plc
$39.67BUSDP/E 18.4
SDZ
Sandoz Group AG
$34.93BUSDP/E 60.5
HLN
Haleon plc
$32.73BUSDP/E 19.0
ZTS
Zoetis Inc.
$29.57BUSDP/E 11.8
ZOE
Zoetis Inc.
$28.56BUSDP/E 12.2
UTHR
United Therapeutics Corporation
$23.38BUSDP/E 19.5
VTRS
Viatris Inc.
$20.09BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.43BUSDP/E 112.9
NBIX
Neurocrine Biosciences, Inc.
$14.58BUSDP/E 21.0
IPN
Ipsen S.A.
$12.99BUSDP/E 23.5
ELAN
Elanco Animal Health Incorporated
$11.17BUSD
RDY
Dr. Reddy's Laboratories Limited
$10.22BUSDP/E 27.9
KRK
Krka, d. d.
$8.66BUSDP/E 19.3
ALKS
Alkermes plc
$6.95BUSDP/E 109.1
HIMS
Hims & Hers Health, Inc.
$6.89BUSD
AMRX
Amneal Pharmaceuticals, Inc.
$6.84BUSDP/E 40.1

Key Statistics

Company
Market Cap76.97M USD
Enterprise Value—
Revenue (TTM)—
Gross Profit33.18M USD
Net Income (TTM)-35.71M USD
Revenue/Share—
Last Price5.130 USD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees285
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-3.59
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B0.70
EPS (TTM)-0.95
EPS (Forward)-1.48
52W Range
0.680082% of range6.100
52W High6.100 USD
52W Low0.6800 USD
Profitability
Gross Margin12.28%
Oper. Margin0.00%
EBITDA Margin-20.48%
Profit Margin-13.22%
ROE-9.01%
ROA-5.17%
Growth
Revenue Growth23.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF16.84M USD
CapEx (TTM)3.55M USD
FCF Margin—
FCF Yield-48.63%
Net Debt—
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.46
Current Ratio1.48
Quick Ratio0.91
Book Value/Sh7.59 USD
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:5
Split DateAug 24, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.15.00M
Float7.35M
Insiders38.21%
Institutions1.05%
Short Interest
Short Ratio0.1d
Short % Float0.05%
Short % Out.0.04%
Shares Short5.57K
Short (prev mo.)2.24K
Technical
SMA 505.112 (+0.4%)
SMA 2004.695 (+9.3%)
Beta0.64
S&P 52W Chg16.45%
Avg Vol (30d)20.28K
Avg Vol (10d)5.26K
Technical Indicators
RSI (14)60.3
MACD0.4801
MACD Signal0.6323
MACD Hist.-0.1522
BB Upper5.500 USD
BB Middle5.281 USD
BB Lower5.063 USD
BB Width8.27%
ATR (14)0.2129 USD
Vol Ratio (20d)1.62x